Summary of Trading Off Q2 > Annual Report Bottom - As At

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
134
Summary of Trading Off Q2 > Annual Report Bottom - As At Close August 10 [no change].

Bought at .0006:

May 11: 1M [rounded up]
June 1: 1M [rounded up]
June 20: 1M [rounded up]
June 22: 13M [rounded down]
June 25: 6M [rounded up]
June 26: 82M [rounded down]
June 28: 5M [rounded up]
June 29: 3M [rounded up]
July 9: 2M [rounded down]
July 19: 1M [rounded up]

Total: 115M

Bought at .0005:

January 19: 3M
January 23: 3M
May 8: 2M
May 9: 12M [rounded down]
May 10: 34M [rounded up]
May 11: 21M [rounded down]
May 14: 3M [rounded up]
May 18: 5M
May 21: 1M [rounded down]
May 23: 1M [rounded up]
May 31: 20M [rounded up]
June 1: 61M
June 5: 6M [rounded up]
June 19: 26M [rounded down]
June 20: 95M [rounded up]
June 21 22M [rounded up]
June 22: 9M [rounded down]
June 26: 13M
June 27: 13M [rounded up]
June 28: 32M [rounded down]
June 29 6M [rounded up]
July 2: 29M [rounded up]
July 5: 17M [rounded up]
July 6: 1M [rounded down]
July 9: 14M
July 11: 1M [rounded up]
July 12: 8M [rounded down]
July 13: 9M [rounded up]
July 16: 7M [rounded down]
July 18: 1M [rounded up]
July 19: 53M [rounded up]
July 20: 24M [rounded down]
July 24:14M [rounded up]
August 1: 1M [rounded up]

Total: 567M

Bought at .0004:

August 23: 9.5M
September 1: 1.5M
September 6: 4M
September 7: 1M
September 11: 5M
September 15: 63M
September 21: 1M
September 26: 62M
September 27: 65M
September 28: 36M
September 29: 7M
October 2: 13M
October 3: 1M
October 5: 5M
October 6: 11M
October 9: 4M
October 11: 14M
October 12: 1M
October 16: 9M
October 17: 6M
October 18: 2M
October 19: 1M
October 23: 2M
October 24: 3M
October 25: 7M
October 26: 16M
October 31: 3M
November 2: 1M
November 3: 3M
November 6: 4M
November 7: 1M
November 9: 1M
November 10: 4M
November 14: 3M
November 16: 1M
November 17: 5M [discounting double print of a 2M buy]
November 20: 10M
November 21: 2M
November 22: 2M
November 24: 2M
November 27: 4M
November 28: 1M
November 30: 3M
December 5: 2M
December 12: 1M
December 14: 1M
December 28: 9M
December 29: 4M
January 3: 7M
January 5: 1M [rounded down from 1.4M]
January 8: 1M
January 11: 51M
January 19: 20M
January 24: 3M
January 29: 1M [rounded up from 684K with 500K from January 26]
January 30: 2M [rounded up from 1.7M]
February 2: 6M
February 5: 2M
February 6: 4M
February 8: 5M
February 9: 2M
February 12: 2M
February 13: 2M
February 14: 3M
February 15: 8M
February 16: 1M
March 2: 4M [rounded up]
March 5: 4M [rounded down]
March 6: 1M
March 7: 1M [rounded up]
March 8: 2M [rounded down]
March 9: 3M [rounded up]
March 12: 11M
March 13: 5M
March 22: 12M
March 23: 6M [rounded down]
March 28: 2M
Aoril 17: 1M
April 25: 1M [rounded up]
May 4: 13M [rounded up]
May 7: 57M
May 8: 13M [rounded down]
May 9: 16M [rounded down]
May 10: 6M
May 14: 10M [rounded down]
May 15: 15M [rounded up]
May 16: 2M
May 17: 18M
May 18: 5M
May 21: 8M [rounded down]
May 23: 33M [rounded down]
May 24: 7M [rounded down]
May 29: 2M
May 30: 32M [rounded down]
May 31: 22M [ rounded up]
June 1: 32M [rounded down]
June 5: 5M [rounded down]
June 6: 14M [rounded down]
June 7: 5M [rounded up]
June 8: 3M [rounded up]
June 12: 14M [rounded up]
June 13: 2M [rounded down]
June 14: 41M [rounded up]
June 15: 33M [rounded up]
June 18: 18M [rounded down]
June 19: 3M [rounded down]
June 20: 1M [rounded down]
June 28: 1M
July 9: 1M [rounded down]
July 18: 25M
July 19: 2M
July 20: 1M [rounded down]
July 23: 3M [rounded down]
July 24: 2M [rounded up]
July 25: 3M [rounded up]
July 26: 84M [rounded down]
July 31: 3M [rounded up]
August 1: 31M [rounded down]
August 2: 2M
August 7: 2M [rounded down]

Total: 1176M

Bought at .0003:

September 15: 1M
October 2: 3M
October 6: 3M
October 9: 7M
October 17: 1M [rounded up from 850K]
November 22: 3M
November 30: 1M
December 1: 11M
December 5: 30M
December 6: 4M [rounded down from 4.4M]
December 7: 8M
December 8: 13M
December 12: 2M
December 14: 96M
December 15: 13M
December 18: 5M
December 19: 3M
December 21: 2M
December 22: 2M
December 27: 2M
December 28: 3M
December 29: 8M
January 2: 1M [rounded down from 1.5M]
January 3: 13M
January 4: 1M [rounded up from 800K]
January 10: 1M
January 18: 13M [rounded down from 13.4M]
February 6: 1M
February 12: 3M
February 14: 1M [rounded up]
February 16: 1M
February 21: 2M [rounded down]
March 1: 1M [rounded up]
March 14: 4M
March 20: 12M [rounded down]
March 22: 5M
March 23: 7M
March 28: 4M [rounded up]
April 2: 11M [rounded up]
April 3: 10M [rounded down]
April 5: 8M [rounded down]
April 9: 3M [rounded down]
April 10: 1M [rounded down]
April 11: 5M [rounded up]
April 12: 2M
April 13: 2M [rounded up]
April 17: 13M
April 18: 3M [rounded up]
May 1: 4M
May 24: 1M [rounded up]
June 12: 4M
June 14: 2M [rounded down]
July 26: 17M
August 7: 1M

Total 380M

Bought at .0002:

April 17: 5M [rounded up]

Total: 5M [out of 138M bid]



















American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Morgan Conque: Veterans' Assets Meet Business Leadership

Updated Category News Views 125

Celebrating Veterans in Business When the world's largest tribute to veteran talent lands in Dallas on December 10, it won't just be about pomp and ceremony. It's about showcasing remarkable stories like Morgan Conque's—someone who's managed to transcend her past military distinction and drive the business world with the same vigor. From Military Precision to Business...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 83

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Habitat for Humanity AZ's Unique Gala: An Overview

Updated Category News Views 33

Mark Your Calendars: A Night to Celebrate Listen up, Central Arizona, because I'm giving you the lowdown on Habitat for Humanity Central Arizona's big night out. "Blueprints & Blue Jeans" - it's the gala that's ditching the formalities for some good old-fashioned community fun, but with a seriously important mission at its heart. Mark your calendars for Friday, March 5,...

Continue Reading
Ez1099 2026: Simplifying Tax Filing Game Plan

Updated Category News Views 99

Simplifying Tax Filing: Say Goodbye to TCCs The gripes of chasing after IRS Transmitter Control Codes are about to be as outdated as rotary phones. Halfpricesoft has just rolled out its ez1099 2026 tax software, and folks, it's ready to change the game for the 2027 tax season. Forget the traditional IRS Fire system, as it's about to be retired soon—I mean, who wants to...

Continue Reading
CorelDRAW's Flexibility: A Designer's One-Time Buy?

Updated Category News Views 87

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

Continue Reading
Brigham Nurses Set to Strike: MGB Board Faces Scrutiny

Updated Category News Views 50

Pressure Cooker: MGB in the Hot Seat Nurses from Brigham and Women's Hospital aren't backing down, folks. They're feverishly preparing for a full-scale strike, set to kick off on November 12, if Mass General Brigham (MGB) doesn't budge on contract negotiations. Since today is November 6, they've got just a few days to find common ground. Let me tell you, the stakes...

Continue Reading
BETR Investors Face Deadline in Class Action Case

Updated Category News Views 96

Investor Deadline Looms for BETR Losses Ah, the tangled web of finance promises and posturing! Investors in Better Home & Finance Holding Company (NASDAQ: BETR) are now standing at a financial crossroads, thanks to an unfolding legal drama. You've got until November 20, 2026, to align your ducks and join a federal securities class action lawsuit, put forth by Hagens...

Continue Reading
TCL CSOT's OLED Move In Marks Next Phase of Growth

Updated Category News Views 96

A Landmark Moment in OLED Manufacturing Alright, let me drop a quick line here. TCL CSOT just shifted gears with their t8 production line in Guangzhou. It’s not your typical assembly line story—this one's all about pulling the future into the present. We're talking the world's first 8.6-generation Inkjet Printing OLED production line, for crying out loud. They've just...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 182

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing Demand in Pharmaceutical Excipients Market by 2031

Updated Category News Views 182

Let’s cut to the chase—the pharmaceutical excipients market is heating up. It's not just a smattering of growth here and there; we’re talking about a projected value that’s set to smash through USD 17.13 billion by 2031. That’s a juicy compound annual growth rate (CAGR) of 6.8% from 2024 to 2031 according to SkyQuest Technology. Why the Surge? What's fueling...

Continue Reading
Natural Retreats Enhances Guest Experience with Track Software

Updated Category News Views 354

Natural Retreats Elevates Guest Experience with New Tech Natural Retreats, a leader in the luxury vacation rental market, is making waves with its recent partnership with Track Hospitality Software. This collaboration marks a pivotal shift in how the company operates, ensuring that customer service reaches new heights. By adopting Track's cloud-based property management...

Continue Reading
Lower Factory Input Prices Signal Inflation Relief

Updated Category Economy Views 323

U.S. Manufacturing Sector Contracts for Third Consecutive Month June's U.S. manufacturing sector contracted for the third month running. From 48.7 in May, the Institute for Supply Management (ISM) recorded that its manufacturing PMI dropped to 48.5 in June. A PMI reading less than fifty suggests contraction. Ten percent or so of the U.S. economy is manufacturing....

Continue Reading
Investors Brace for Talen Energy's Earning Report This Week

Updated Category News Views 159

Talen Energy: Prepping for the Earnings Showdown Pencil this one in: February 26, 2026. That’s the big day when Talen Energy (NASDAQ:TLN) rolls out its quarterly earnings report. Investors are chomping at the bit, as EPS is projected to hit a solid $3.68. Get your game faces on folks, because this one could shake up sentiment across the board. The Whisperer’s Corner:...

Continue Reading
Legal Insights: Sage Therapeutics Under Investigation for Alleged Misconduct

Updated Category News Views 119

Understanding the Investigation Surrounding Sage Therapeutics The legal world is buzzing with developments concerning Sage Therapeutics, Inc. (NASDAQ: SAGE), a prominent name in the pharmaceutical industry. Recently, Faruqi & Faruqi, LLP—a respected national securities law firm—has ramped up efforts to investigate potential claims on behalf of investors interested in...

Continue Reading